Institutional Repository of Vilnius University
Aβ42-SUP35Δ5-112-GFP mutantinio varianto kūrimas /
Abstract
dc:descriptionOne of the main causes of dementia is Alzheimer's disease, of which one of the main triggers is considered to be the Aβ42 amyloid, which has the property of aggregating and forming amyloids. Yeast systems are one of the tools used to identify drugs against Alzheimer's disease-causing amyloids. The aim of this study was to fuse the Aβ42 and modified yeast SUP35-GFP genes using the overlapping fragment extension PCR method. To achieve this goal, the sequence of the Aβ42 gene in the pET-3a-Aβ42 plasmid was determined, and primers were constructed, which were further used for the fusion of the Aβ42 and SUP35Δ1-112-GFP genes. During the work, the concentration of DMSO used during PCR was optimized, and the optimal concentration of DMSO was determined to be 5%. Using the splicing by overlapping fragment extension PCR method, the Aβ42 and SUP35-GFP genes were successfully fused, resulting in the Aβ42-SUP35Δ5-112-GFP construct. Additionally, the control SUP35Δ5-112-GFP construct (without the Aβ42 sequence) was successfully obtained. Analysis of the sequencing results confirmed the introduction of targeted mutations.
Degree
thesis:*- Grantor dc:publisher
- Institutional Repository of Vilnius University
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Vasiliauskas, Rokas Saulius,
Rights
dc:rights- Statement dc:rights
-
- info:eu-repo/semantics/openAccess
- Language dc:language
- lit
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://repository.vu.lt/VU:ELABAETD192839152&prefLang=en_US